BTG CASE STUDIES > R&D

Preparing For a Major R&D Transformation

The head of R&D at a F500 pharmaceutical company was preparing for a major transformation aimed at using new technologies to drive more efficient decisions throughout the drug development process. McKinsey was helping her develop top-line strategies. But the project had already been organized into…

READ MORE


Hematology Market Planning

The dynamic culture at this biotech company creates opportunities for employees as they rotate responsibilities and projects. It also creates opportunities for the external consultants the company relies on to supplement internal teams and minimize disruptions to productivity. In one recent example, the company’s Market…

READ MORE


Addressing Complexity in R&D Contracting

As a global pharma company grew, so too did the complexity of its R&D contracting needs. Demand from R&D was straining current processes, and internal teams were struggling to avoid delays while managing multiple stakeholders and fulfilling all process requirements. Internal work had identified several…

READ MORE


Indication Prioritization

The VP of Global Marketing at a F200 pharma company was reviewing a promising drug about to enter Phase II of R&D. The company’s lean team had already completed a broad indication assessment, but they needed help preparing a more detailed opportunity assessment that leveraged…

READ MORE


Product Development Roadmap

Through a partnership with an academic laboratory, a global non-profit had developed a promising malnutrition technology. The challenge: creating a strategy that would take the technology out of the lab and into patient populations in Africa and Asia. The group’s researchers had little experience with…

READ MORE


Send this to a friend